Address
Oxford Finance LLC
San Diego, CA 00000
United States
Oxford Finance LLC
Palo Alto, CA 00000
United States
Email
Website
Recent investment activity
KANDO id: 82556
Corporate information
Official name
Oxford Finance Limited Liability Company
Registration country
Company type
Provider of capital exclusively to life sciences and healthcare services companies worldwide.Overview
Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $6 billion in loans, with lines of credit ranging from $5 million to $150 million. Oxford is headquartered in Alexandria, Va., with additional offices in San Diego, Calif.; Palo Alto, Calif.; and the greater Boston and New York City areas.
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 17 of 17| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
AirXpanders | A medical device company that has developed the AeroForm tissue expander. | Venture Initial investment | |||
|
|
Avanir Pharmaceuticals Inc | A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. | Debt Initial investment | |||
|
|
Ceptaris Therapeutics Inc | Specialty pharmaceuticals company. | Debt Initial investment | |||
|
|
Endocyte Inc | Folate-based cancer and autoimmune disease therapies | N/A Initial investment | |||
|
|
EUSA Pharma Inc | Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care | N/A Initial investment | |||
|
|
Innovative Spinal Technologies Inc | Spine technology company. | N/A Initial investment | |||
|
|
Intuity Medical Inc | N/A Initial investment | ||||
|
|
MediciNova Inc | Focuses on acquiring and developing novel, small-molecule therapeutics for the US market. | Debt Initial investment | |||
|
NanoString Technologies Inc | A life sciences company, markets solutions for detecting and counting large sets of target molecules in biological samples for researchers. | N/A Initial investment | |||
|
|
NeoVista Inc | Debt Initial investment | ||||
|
|
SkinMedica Inc | Engages developing, acquiring, and commercializing prescription and non-prescription skin care products that improve the appearance of skin. | N/A Initial investment | |||
|
|
TearScience Inc | Developer of a diagnostic and treatment devices targeted at the root cause of the majority of dry eye cases. | Debt | |||
|
|
Tengion Inc | A leading regenerative medicine company. | Series C Initial investment | |||
|
|
Tethys Bioscience Inc | N/A Initial investment | ||||
|
|
Tranzyme Pharma | Drug discovery and development, focused on gastroenterology indications | Debt Initial investment | |||
|
|
Vitae Pharmaceuticals Inc | Drug discovery company developing optimized drugs using proprietary computational drug design platform. | N/A Initial investment | |||
|
Zogenix Inc | A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. | Series B Initial investment |